394
Views
19
CrossRef citations to date
0
Altmetric
Liver and biliary tract

Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication

, , , , , , , & show all
Pages 1111-1117 | Received 01 Mar 2011, Accepted 25 Apr 2011, Published online: 30 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

. (2011) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:9, pages 1027-1028.
Read now

Articles from other publishers (18)

Hiroshi Takahashi, Tatsuo Kanda, Naoki Matsumoto, Toshikatsu Shibata, Kazushige Nirei, Akinori Tamura, Shunichi Matsuoka, Kazumichi Kuroda & Mitsuhiko Moriyama. (2020) Analysis of full-length hepatitis B virus genome from chronic hepatitis B-patients with higher alanine aminotransferase elevation. Future Virology 15:7, pages 429-439.
Crossref
Spilios Manolakopoulos, Athanasia Striki, Vasilios Papastergiou, Nikoleta Perlepe, Konstantinos Zisimopoulos, Afroditi Papazoglou, Melanie Deutsch, Nikolaos Papadopoulos, Christos Triantos, John Goulis & George Papatheodoridis. (2020) Persistence and adherence to nucleos(t)ide analogues in chronic hepatitis B: a multicenter cohort study. European Journal of Gastroenterology & Hepatology 32:5, pages 635-641.
Crossref
Raquel Scherer de Fraga, Victor Van Vaisberg, Luiz Cláudio Alfaia Mendes, Flair José Carrilho & Suzane Kioko Ono. (2020) Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review. Journal of Gastroenterology 55:5, pages 496-514.
Crossref
Taku Mizutani, Shunichi Matsuoka, Daiichirou Kikuta, Jou Hayama, Shintaro Nagai, Naoki Matsumoto, Hitomi Nakamura, Kazushige Nirei, Tatsuo Kanda, Mitsuhiko Moriyama, Katsuhiro Miura, Masami Takei & Masahiko Sugitani. (2019) Successful Management of a Patient with Multiple Nucleos(t)ide Analogue-Resistant Hepatitis B Virus and Diffuse Large B Cell Lymphoma Using Tenofovir Disoproxil Fumarate: A Case ReportSuccessful Management of a Patient with Multiple Nucleos(t)ide Analogue-Resistant Hepatitis B Virus and Diffuse Large B Cell Lymphoma Using Tenofovir Disoproxil Fumarate: A Case Report. Journal of Nihon University Medical Association 78:5, pages 295-300.
Crossref
Suzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Jacob George, Amany Zekry & Lisa Maher. (2017) Factors Associated with Non-Adherence to HBV Antiviral Therapy. Antiviral Therapy 23:5, pages 425-433.
Crossref
In Du Jeong, Seok Won Jung, Bo Ryung Park, Byung Uk Lee, Jae Ho Park, Byung Gyu Kim, Sung-Jo Bang, Jung Woo Shin & Neung Hwa Park. (2017) Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naïve Patients with Chronic Hepatitis B. Digestive Diseases and Sciences 62:10, pages 2908-2914.
Crossref
Masato Nakamura, Tatsuo Kanda, Xia Jiang, Yuki Haga, Koji Takahashi, Shuang Wu, Shin Yasui, Shingo Nakamoto & Osamu Yokosuka. (2017) Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis. PLOS ONE 12:5, pages e0177302.
Crossref
Suzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Amany Zekry, Gregory J Dore, Jacob George & Lisa Maher. (2017) Factors associated with HBV Virological Breakthrough. Antiviral Therapy 22:1, pages 53-60.
Crossref
Suzanne Polis, Iryna Zablotska-Manos, Amany Zekry & Lisa Maher. (2017) Adherence to Hepatitis B Antiviral Therapy. Gastroenterology Nursing 40:3, pages 239-246.
Crossref
Lotte G. van Vlerken, Pauline Arends, Faydra I. Lieveld, Joop E. Arends, Willem Pieter Brouwer, Peter D. Siersema, Harry L. Janssen & Karel J. van Erpecum. (2015) Real life adherence of chronic hepatitis B patients to entecavir treatment. Digestive and Liver Disease 47:7, pages 577-583.
Crossref
Wai-Kay Seto, Aric Josun Hui, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Kevin Sze-Hang Liu, Ching-Lung Lai, Man-Fung Yuen & Henry Lik-Yuen Chan. (2015) Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study. Gut 64:4, pages 667-672.
Crossref
Akinobu Tawada. (2015) Current and future directions for treating hepatitis B virus infection. World Journal of Hepatology 7:11, pages 1541.
Crossref
Qian Qiu. (2015) Impact of partial reimbursement on hepatitis B antiviral utilization and adherence. World Journal of Gastroenterology 21:32, pages 9588.
Crossref
Shingo Nakamoto, Tatsuo Kanda, Chiaki Nakaseko, Emiko Sakaida, Chikako Ohwada, Masahiro Takeuchi, Yusuke Takeda, Naoya Mimura, Tohru Iseki, Shuang Wu, Makoto Arai, Fumio Imazeki, Kengo Saito, Hiroshi Shirasawa & Osamu Yokosuka. (2014) Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment. International Journal of Molecular Sciences 15:11, pages 21455-21467.
Crossref
Sung-Jo Bang, Byung Gyu Kim, Jung Woo Shin, Hyeong Uk Ju, Bo Ryung Park, Min-Ho Kim, Chang Jae Kim, Jae Ho Park, In Du Jeong, Seok Won Jung & Neung Hwa Park. (2013) Clinical course of patients with insufficient viral suppression during entecavir therapy in genotype C chronic hepatitis B. Digestive and Liver Disease 45:7, pages 600-605.
Crossref
Guan‐Huei Lee, Masafumi Inoue, Jimmy K.‐P. Toh, Roxanne H.‐H. Chong, Myat‐Oo Aung, Evelyn S.‐C. Koay & Seng‐Gee Lim. (2013) Two‐step evolution of the hepatitis B drug‐resistant mutations in a patient who developed primary entecavir resistance. Liver International 33:4, pages 642-646.
Crossref
T.-T. Zhang, J. Ye, S.-L. Xia, Y.-F. Zhang, Q. Su, Z.-H. Zhang & X. Li. (2012) Polymorphism of estrogen receptor alpha (ESR1) is associated with virological response to entecavir (ETV) in nucleoside-naïve adult patients with chronic hepatitis B. Infection 41:2, pages 371-378.
Crossref
Maximilian Lee. (2012) Adherence with Use of Oral Agents in the Treatment of Chronic Hepatitis B. Current Hepatitis Reports 11:2, pages 70-74.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.